Affordable HPV self-testing for cervical cancer prevention in Nigeria
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
['FUNDING_U01'] · WASHINGTON UNIVERSITY · NIH-10912477
This study is creating an easy-to-use and affordable HPV self-testing kit for women in Nigeria to help them take control of their health and reduce the risk of cervical cancer.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10912477 on ClinicalTrials.gov |
What this research studies
This research aims to develop a user-friendly and affordable HPV self-testing kit specifically designed for women in Nigeria, where cervical cancer is a leading cause of death. The project will adapt an existing HPV assay using innovative techniques to ensure it is suitable for local conditions. By involving women in the design process through crowdsourcing and learning communities, the research seeks to empower them to take charge of their health. The goal is to increase access to HPV screening and ultimately reduce cervical cancer rates in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 30-49 in Nigeria who are eligible for cervical cancer screening.
Not a fit: Patients outside the age range of 30-49 or those not residing in Nigeria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates among women in Nigeria, leading to earlier detection and better outcomes.
How similar studies have performed: Similar approaches to decentralized and self-administered testing have shown promise in other regions, indicating potential for success in this novel application.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: IWELUNMOR, JULIET — WASHINGTON UNIVERSITY
- Study coordinator: IWELUNMOR, JULIET
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Cancers